Evidence map›Paper›PMID 37971948›Full record

ArticleJournal of global health2023

Development of a composite scoring system to rank communities at high risk of zero-dose children in Cameroon: A geospatial analysis.

Yauba Saidu, Valirie N Agbor, Pietro Di Mattei, Sangwe C Nchinjoh, Nnang N Edwidge, Andreas A Njoh, Nkwain J Muteh, Marta Prescott, Owens Wiwa, Demba Diack and 4 more

Abstract read
In one paragraph

Article in Journal of global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yauba SaiduClinton Health Access Initiative Inc., Yaoundé, Cameroon.
Valirie N AgborClinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Pietro Di MatteiGavi, the Vaccine Alliance, Geneva, Switzerland.
Sangwe C NchinjohClinton Health Access Initiative Inc., Yaoundé, Cameroon.
Nnang N EdwidgeClinton Health Access Initiative Inc., Yaoundé, Cameroon.
Andreas A NjohExpanded Program on Immunization, Cameroon Ministry of Public Health, Yaoundé, Cameroon.
Nkwain J MutehGavi, the Vaccine Alliance, Geneva, Switzerland.
Marta PrescottGlobal Analytics and Implementation Research Team, Clinton Health Access Initiative Inc., Boston, USA.
Owens WiwaClinton Health Access Initiative Inc., Yaoundé, Cameroon.
Demba DiackGavi, the Vaccine Alliance, Geneva, Switzerland.
Junie FlegereGavi, the Vaccine Alliance, Geneva, Switzerland.
Emanuele MontomoliInstitute for Global Health, Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Sue A Costa ClemensInstitute for Global Health, Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Ralf ClemensInstitute for Global Health, Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite growing efforts to improve access to vaccination, millions of children, especially in developing countries, have not received a single dose of diphtheria, tetanus, and pertussis (DTP) vaccine. Consequently, they are often called zero-dose children (ZDC). With limited health resources, prioritising communities for rapid and mass zero-dose catch-up vaccination in missed communities to avert epidemic outbreaks is complicated by unreliable denominators used to compute vaccination coverages. Incorporating other indicators of access and utilisation of vaccination services can help with identifying and ranking missed communities based on the likelihood of finding ZDC. We described the process of generating a scoring method to rank health areas in Cameroon based on their likelihood of containing ZDC. Methods: We used geospatial analysis to compute and aggregate health area characteristics, including hard-to-reach (HTR) areas (defined as areas of settlement above a one- (for urban areas) or 15-kilometre radius (for rural areas) beyond a vaccinating health facility), amount of area covered by slums and new area settlement, and percentage of children unvaccinated for DTP-1. We attributed a weight based on the ability to limit accessibility or utilisation of vaccination services to each characteristic and computed the score as a weighted average of health area characteristics. The health area score ranged from 0 to 1, with higher scores representing a higher likelihood of containing ZDC. We stratified the analysis by rural and urban health areas. Results: We observed substantial district and regional variations in health area scores, with hotspots health areas (administrative level 4) observed in the Far North (0.83), North (0.81), Adamawa (0.80), East (0.75), and South West (0.67) regions. The Adamawa region had the highest percentage of health areas with the highest score (78%), followed by the East (50%), West (48%), and North (46%) regions. For most regions (Far North, South, South West, Littoral, West, and North West), DTP-1 contributed the most to the score. However, HTR settlement areas within a health area contributed substantially to the overall score in the East, North, and Adamawa regions. Conclusions: We found substantial variations in health area scores with hotspots in the Far North, North, Adamawa, East, and South West regions. Although DTP-1 could be used as an indicator to identify health areas with ZDC for most communities, HTR settlement area was a valuable indicator in ranking priority health areas in the East, North, and Adamawa regions, further emphasising the need to consider other indicators before prioritisation.

Indexed as

Diphtheria-Tetanus-Pertussis VaccineVaccinationCameroonChildHumansInfantMass VaccinationVaccination CoverageDiphtheria-Tetanus-Pertussis Vaccine

Identifiers

PMID37971948
PMCPMC10653342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.